SCHEMBL23935895

SCHEMBL23935895

CCN(C)C(=O)c1cccc(C)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.53
ESR2 Q92731 1/20 0.53
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.44
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 3/20 0.42
MAPK14 Q16539 1/20 0.41
HPGD P15428 2/20 0.41
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
KEAP1 Q14145 1/20 0.40
UTS2R Q9UKP6 2/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 2/20 0.39
AKR1B10 O60218 1/20 0.39
TRPA1 O75762 1/20 0.39
ABCB11 O95342 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15343524 0.85 KMT2A (0.67) KMT2AMEN1MAPK1TSHRTDP1
SCHEMBL509012 0.84 TSHR (0.57) ESR1ESR2KMT2AMEN1MAPK1
Bromide SCHEMBL7115821 0.83 ESR1 (0.50) ESR1ESR2KMT2AMEN1MAPK1
SCHEMBL1810392 0.81 ESR1 (0.59) ESR1ESR2KMT2AMEN1TSHR
Bromide SCHEMBL6553179 0.79 ESR1 (0.53) ESR1ESR2KMT2AMEN1MAPK1
Hydrochloric Acid SCHEMBL6554710 0.79 ESR1 (0.53) ESR1ESR2KMT2AMEN1MAPK1
Fluoride Ion SCHEMBL6553165 0.79 ESR1 (0.53) ESR1ESR2KMT2AMEN1MAPK1
Bromide SCHEMBL6554342 0.78 ESR1 (0.49) ESR1ESR2KMT2AMEN1MAPK1
Hydrochloric Acid SCHEMBL6552774 0.78 ESR1 (0.49) ESR1ESR2KMT2AMEN1MAPK1
Fluoride Ion SCHEMBL7108100 0.78 ESR1 (0.49) ESR1ESR2KMT2AMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3896064-A1 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS CANCER OSAKA THYROID (COT) MODULATORS FOR TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Gilead Sciences, Inc. (US) 2021-10-20 EP disclosed